140 related articles for article (PubMed ID: 32026656)
1. Risk factors for early death among ovarian cancer patients: a nationwide cohort study.
Mosgaard BJ; Meaidi A; Høgdall C; Noer MC
J Gynecol Oncol; 2020 May; 31(3):e30. PubMed ID: 32026656
[TBL] [Abstract][Full Text] [Related]
2. Do stage of disease, comorbidity or access to treatment explain socioeconomic differences in survival after ovarian cancer? - A cohort study among Danish women diagnosed 2005-2010.
Ibfelt EH; Dalton SO; Høgdall C; Fagö-Olsen CL; Steding-Jessen M; Osler M; Johansen C; Frederiksen K; Kjær SK
Cancer Epidemiol; 2015 Jun; 39(3):353-9. PubMed ID: 25841586
[TBL] [Abstract][Full Text] [Related]
3. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
4. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
5. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
Guldbrandt LM
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic position and survival after lung cancer: Influence of stage, treatment and comorbidity among Danish patients with lung cancer diagnosed in 2004-2010.
Dalton SO; Steding-Jessen M; Jakobsen E; Mellemgaard A; Østerlind K; Schüz J; Johansen C
Acta Oncol; 2015 May; 54(5):797-804. PubMed ID: 25761702
[TBL] [Abstract][Full Text] [Related]
7. Does stage of cancer, comorbidity or lifestyle factors explain educational differences in survival after endometrial cancer? A cohort study among Danish women diagnosed 2005-2009.
Seidelin UH; Ibfelt E; Andersen I; Steding-Jessen M; Høgdall C; Kjær SK; Dalton SO
Acta Oncol; 2016 Jun; 55(6):680-5. PubMed ID: 27144961
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in soft tissue sarcoma.
Maretty-Nielsen K
Dan Med J; 2014 Nov; 61(11):B4957. PubMed ID: 25370967
[TBL] [Abstract][Full Text] [Related]
9. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
[TBL] [Abstract][Full Text] [Related]
10. Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.
Folkestad L
Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619932
[TBL] [Abstract][Full Text] [Related]
11. Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002.
Hannibal CG; Cortes R; Engholm G; Kjaer SK
Acta Obstet Gynecol Scand; 2008; 87(12):1353-60. PubMed ID: 18951210
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of ovarian cancer subsequent to venous thromboembolism: a nationwide Danish cohort study.
Tetsche MS; Nørgaard M; Pedersen L; Lash TL; Sørensen HT
BMC Cancer; 2006 Jul; 6():189. PubMed ID: 16846496
[TBL] [Abstract][Full Text] [Related]
13. Comorbidity is an independent prognostic factor for the survival of ovarian cancer: a Danish register-based cohort study from a clinical database.
Sperling C; Noer MC; Christensen IJ; Nielsen ML; Lidegaard Ø; Høgdall C
Gynecol Oncol; 2013 Apr; 129(1):97-102. PubMed ID: 23290990
[TBL] [Abstract][Full Text] [Related]
14. Factors Affecting Short-term Mortality in Women With Ovarian, Tubal, or Primary Peritoneal Cancer: Population-Based Cohort Analysis of English National Cancer Registration Data.
Barclay M; Gildea C; Poole J; Hirschowitz L; Menon U; Nordin A
Int J Gynecol Cancer; 2016 Jan; 26(1):56-65. PubMed ID: 26509852
[TBL] [Abstract][Full Text] [Related]
15. Low-dose aspirin use and the risk of ovarian cancer in Denmark.
Baandrup L; Kjaer SK; Olsen JH; Dehlendorff C; Friis S
Ann Oncol; 2015 Apr; 26(4):787-792. PubMed ID: 25538177
[TBL] [Abstract][Full Text] [Related]
16. Validation of a comorbidity index for use in obstetric patients: A nationwide cohort study.
Bliddal M; Möller S; Vinter CA; Rubin KH; Gagne JJ; Pottegård A
Acta Obstet Gynecol Scand; 2020 Mar; 99(3):399-405. PubMed ID: 31628857
[TBL] [Abstract][Full Text] [Related]
17. Predictors of ovarian cancer survival: a population-based prospective study in Sweden.
Yang L; Klint A; Lambe M; Bellocco R; Riman T; Bergfeldt K; Persson I; Weiderpass E
Int J Cancer; 2008 Aug; 123(3):672-9. PubMed ID: 18498135
[TBL] [Abstract][Full Text] [Related]
18. Survival of ovarian cancer patients in Denmark: Results from the Danish gynaecological cancer group (DGCG) database, 1995-2012.
Edwards HM; Noer MC; Sperling CD; Nguyen-Nielsen M; Lundvall L; Christensen IJ; Høgdall C
Acta Oncol; 2016 Jun; 55 Suppl 2():36-43. PubMed ID: 27355258
[TBL] [Abstract][Full Text] [Related]
19. The implications of age and comorbidity on survival following epithelial ovarian cancer: summary and results from a Centers for Disease Control and Prevention study.
O'Malley CD; Shema SJ; Cress RD; Bauer K; Kahn AR; Schymura MJ; Wike JM; Stewart SL
J Womens Health (Larchmt); 2012 Sep; 21(9):887-94. PubMed ID: 22816528
[TBL] [Abstract][Full Text] [Related]
20. Risk of breast cancer among women with benign ovarian tumors: a Danish nationwide cohort study.
Gottschau M; Jensen A; Reinholdt K; Guleria S; Munk C; Mellemkjær L; Kjær SK
Breast Cancer Res Treat; 2019 Nov; 178(1):199-205. PubMed ID: 31364000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]